首页> 外文期刊>Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists >Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism.
【24h】

Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism.

机译:成功的甲状旁腺切除术对严重原发性甲状旁腺功能亢进患者代谢性心血管危险因素的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the effect of parathyroidectomy on metabolic abnormalities associated with cardiovascular disease in patients with primary hyperparathyroidism (PHPT). METHODS: Thirty-four patients with PHPT (aged 51.0 +/- 11.8 years, mean +/- standard deviation) underwent assessment before and 1 year after successful parathyroidectomy. A control group of 42 normocalcemic healthy subjects, matched for age and body mass index, was also examined at baseline. We measured serum lipids, glucose, insulin, uric acid, calcium, parathyroid hormone, C-reactive protein, and bone density. Insulin resistance index was evaluated by homeostasis model assessment, and the presence of metabolic syndrome was determined. Because of multiple tests, the level of statistical significance was set at .01. RESULTS: After parathyroidectomy, there was a decrease in diastolic blood pressure (P<.02) and in serum concentrations of uric acid (P<.04) and insulin (P<.009). No difference was observed in rates of metabolic syndrome in patients before and 1 year after parathyroidectomy (23.5% versus 17.6%; P>.46). Insulin resistance index values were also unchanged from before to after parathyroidectomy (1.3 +/- 0.9 and 1.1 +/- 0.9, respectively; P>.68). A substantial increase in spine bone density (5%; P<.05) was noted postoperatively. Multivariate logistic regression analysis, after adjustment for age and body mass index, revealed that parathyroidectomy did not lead to a significant decrease in likelihood of cardiovascular risk-odds ratio (OR), 1.82; 95% confidence interval (CI), 0.53 to 6.21 (P>.34) for the metabolic syndrome and OR, 0.82; 95% CI, 0.17 to 3.88 (P>.8) for the insulin resistance index. CONCLUSION: In this study, surgical treatment had no beneficial effect on cardiovascular risk, as assessed by the metabolic syndrome and insulin resistance markers in patients with PHPT 1 year after parathyroidectomy.
机译:目的:评估甲状旁腺切除术对原发性甲状旁腺功能亢进症(PHPT)患者心血管疾病相关代谢异常的影响。方法:对34例PHPT患者(年龄51.0 +/- 11.8岁,平均+/-标准差)在甲状旁腺切除术成功之前和之后进行了评估。在基线时还检查了年龄和体重指数匹配的42名正常血钙健康受试者作为对照组。我们测量了血清脂质,葡萄糖,胰岛素,尿酸,钙,甲状旁腺激素,C反应蛋白和骨密度。通过稳态模型评估来评估胰岛素抵抗指数,并确定代谢综合征的存在。由于进行了多次测试,因此统计显着性水平设置为0.01。结果:甲状旁腺切除术后,舒张压降低(P <.02),血尿酸(P <.04)和胰岛素(P <.009)的浓度降低。甲状旁腺切除术前和术后1年患者的代谢综合征发生率无差异(23.5%比17.6%; P> .46)。甲状旁腺切除术前后胰岛素抵抗指数值也没有变化(分别为1.3 +/- 0.9和1.1 +/- 0.9; P> .68)。术后脊柱骨密度显着增加(5%; P <.05)。校正年龄和体重指数后,多因素logistic回归分析显示,甲状旁腺切除术未导致心血管风险比(OR)为1.82;代谢综合征的95%置信区间(CI)为0.53至6.21(P> .34),OR为0.82; 95%CI,胰岛素抵抗指数为0.17至3.88(P> .8)。结论:在这项研究中,根据甲状旁腺切除术后1年PHPT患者的代谢综合征和胰岛素抵抗指标评估,手术治疗对心血管风险无有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号